Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain study sheds light on Parkinson's and tics

NCT ID NCT01019343

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Sep 18, 2026 · Updated 5 times

Summary

This completed study from the National Institute of Neurological Disorders and Stroke aimed to better understand how the brain controls movement and what goes wrong in movement disorders like Parkinson's disease, Tourette's syndrome, and dystonia. Over 1,200 adults—both patients and healthy volunteers—took part in various non-treatment procedures such as MRI scans, EEG, and eye-tracking tests. The study did not offer any treatment, but its findings may help future research into causes and potential therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,273 people

The number who actually took part.

Started

Dec 2009

Finished

Oct 2020

Lead sponsor

A government research agency

The lead sponsor is the US National Institutes of Health.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

* INCLUSION CRITERIA: INCLUSION CRITERIA FOR MOVEMENT DISORDER PATIENTS: * Patients will either have a well-defined diagnosis or be a diagnostic dilemma, depending upon the sub-study * Age 18 or older * Able to give informed consent * Agree to not drink caffeine or alcohol for 48 hours before certain study sessions because both agents can modify brain activity and may confound outcome measures. INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: * Age 18 or older. * Able to give informed consent. * Agree to not drink caffeine or alcohol for 48 hours before certain study sessions because both agents may modify the activity of the brain during the study. EXCLUSION CRITERIA: EXCLUSION CRITERIA FOR MOVEMENT DISORDER PATIENTS: * Have used illegal drugs within the past 6 months * Have more than 7 alcoholic drinks a week in the case of a woman or 14 alcoholic drinks a week in the case of a man. * Have had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures. * Have a psychotic disorder, Bipolar Disorder or a current depressive episode. * Have another neurologic disorder than a movement disorder * Have had a head injury where there was a loss of consciousness for more than a few seconds. EXCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: * Have abnormal findings on a neurological examination that we will perform * Have used illegal drugs within the past 6 months * Have more than 7 alcoholic drinks a week in the case of a woman or 14 alcoholic drinks a week in the case of a man * Have had a brain tumor, a stroke, head trauma, epilepsy or a history of seizures. * Have major depression or any major mental disorders (axis I disorders) * Have had a head injury where there was a loss of consciousness for more than a few seconds. ADDITIONAL EXCLUSION CRITERIA FOR MOVEMENT DISORDER PATIENTS AND HEALTHY VOLUNTEERS SPECIFICALLY FOR fMRI: We will follow the NMR Center guidelines for MR safety. Some of the exclusions are: * Have non-MRI compatible metal in the body, such as a cardiac pacemaker, brain stimulator, shrapnel, surgical metal, clips in the brain or on blood vessels, cochlear implants, artificial heart valves or metal fragments in the eye as these make having an MRI unsafe. * Unable to lie flat on the back for the expected length of the experiment up to 3 hours * Have uncontrolled movements of the head * Have an abnormality on the brain imaging or neurologic examination not related to the diagnosis * Uncomfortable being in a small space for the expected length of the experiment up to 3 hours * Pregnancy ADDITIONAL EXCLUSION CRITERIA FOR MOVEMENT DISORDER PATIENTS AND HEALTHY VOLUNTEERS SPECIFICALLY FOR TMS: * Have metal in the eye or skull area, brain stimulator, shrapnel, surgical metal, clips in the brain, cochlear implants, metal fragments in the eye, as these make TMS unsafe. Having a cardiac pacemaker, intracardiac lines, implanted pumps or stimulators are also exclusion criteria. * Have hearing loss.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dystonia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.